Real-time detection of epidermal growth factor receptor expression in fresh oral cavity biopsies using a molecular-specific contrast agent

Elizabeth R. Hsu, Ann M. Gillenwater, M. Qasim Hasan, Michelle D. Williams, Adel K. El-Naggar, Rebecca R. Richards-Kortum

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Early diagnosis of individuals with high risk of developing head and neck squamous carcinoma should lead to decreased morbidity and increased survival. To aid in noninvasive early detection of oral neoplasia in vivo, we have developed a molecular-specific fluorescent contrast agent, consisting of a far-red fluorescent dye coupled to a monoclonal antibody targeted against the epidermal growth factor receptor. In our study, we used organ cultures of normal and neoplastic human oral tissue to evaluate the capabilities of using this contrast agent to enhance clinical diagnosis. Fresh tissue sections were prepared from 34 biopsies of clinically normal and abnormal oral mucosa from 17 consenting patients. Samples were exposed to contrast agent, rinsed and the presence of bound agent was detected using fluorescence confocal microscopy. Simple assays to assess cytotoxicity of the dye used in the agent and to determine labeling efficacy at physiologic temperatures were also performed. Results indicate that the mean fluorescence intensity (MFI) of samples with dysplasia and cancer are higher than that of the normal sample from the same patient, and that this increase in fluorescence could potentially be used in the early detection and delineation of premalignant lesions. Normal tissue could be distinguished from cancer or moderate dysplasia, using either the ratio of the MFI of abnormal to normal tissue or the MFI obtained from the epithelial surface. No detrimental effects from the dye were observed over a 4-day period. These results indicate that the use of this optical contrast agent could yield important clinical advantages for noninvasive early detection and molecular characterization of oral mucosa.

Original languageEnglish (US)
Pages (from-to)3062-3071
Number of pages10
JournalInternational Journal of Cancer
Volume118
Issue number12
DOIs
StatePublished - Jun 15 2006

Fingerprint

Epidermal Growth Factor Receptor
Contrast Media
Mouth
Fluorescence
Biopsy
Mouth Mucosa
Fluorescent Dyes
Coloring Agents
Neoplasms
Organ Culture Techniques
Fluorescence Microscopy
Confocal Microscopy
Early Diagnosis
Squamous Cell Carcinoma
Neck
Head
Monoclonal Antibodies
Morbidity
Temperature
Survival

Keywords

  • Epidermal growth factor receptor
  • Fluorescent contrast agent
  • Molecular-specific contrast agent

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hsu, E. R., Gillenwater, A. M., Hasan, M. Q., Williams, M. D., El-Naggar, A. K., & Richards-Kortum, R. R. (2006). Real-time detection of epidermal growth factor receptor expression in fresh oral cavity biopsies using a molecular-specific contrast agent. International Journal of Cancer, 118(12), 3062-3071. https://doi.org/10.1002/ijc.21720

Real-time detection of epidermal growth factor receptor expression in fresh oral cavity biopsies using a molecular-specific contrast agent. / Hsu, Elizabeth R.; Gillenwater, Ann M.; Hasan, M. Qasim; Williams, Michelle D.; El-Naggar, Adel K.; Richards-Kortum, Rebecca R.

In: International Journal of Cancer, Vol. 118, No. 12, 15.06.2006, p. 3062-3071.

Research output: Contribution to journalArticle

Hsu, Elizabeth R. ; Gillenwater, Ann M. ; Hasan, M. Qasim ; Williams, Michelle D. ; El-Naggar, Adel K. ; Richards-Kortum, Rebecca R. / Real-time detection of epidermal growth factor receptor expression in fresh oral cavity biopsies using a molecular-specific contrast agent. In: International Journal of Cancer. 2006 ; Vol. 118, No. 12. pp. 3062-3071.
@article{de0594a626264097be0ec951c46d80f4,
title = "Real-time detection of epidermal growth factor receptor expression in fresh oral cavity biopsies using a molecular-specific contrast agent",
abstract = "Early diagnosis of individuals with high risk of developing head and neck squamous carcinoma should lead to decreased morbidity and increased survival. To aid in noninvasive early detection of oral neoplasia in vivo, we have developed a molecular-specific fluorescent contrast agent, consisting of a far-red fluorescent dye coupled to a monoclonal antibody targeted against the epidermal growth factor receptor. In our study, we used organ cultures of normal and neoplastic human oral tissue to evaluate the capabilities of using this contrast agent to enhance clinical diagnosis. Fresh tissue sections were prepared from 34 biopsies of clinically normal and abnormal oral mucosa from 17 consenting patients. Samples were exposed to contrast agent, rinsed and the presence of bound agent was detected using fluorescence confocal microscopy. Simple assays to assess cytotoxicity of the dye used in the agent and to determine labeling efficacy at physiologic temperatures were also performed. Results indicate that the mean fluorescence intensity (MFI) of samples with dysplasia and cancer are higher than that of the normal sample from the same patient, and that this increase in fluorescence could potentially be used in the early detection and delineation of premalignant lesions. Normal tissue could be distinguished from cancer or moderate dysplasia, using either the ratio of the MFI of abnormal to normal tissue or the MFI obtained from the epithelial surface. No detrimental effects from the dye were observed over a 4-day period. These results indicate that the use of this optical contrast agent could yield important clinical advantages for noninvasive early detection and molecular characterization of oral mucosa.",
keywords = "Epidermal growth factor receptor, Fluorescent contrast agent, Molecular-specific contrast agent",
author = "Hsu, {Elizabeth R.} and Gillenwater, {Ann M.} and Hasan, {M. Qasim} and Williams, {Michelle D.} and El-Naggar, {Adel K.} and Richards-Kortum, {Rebecca R.}",
year = "2006",
month = "6",
day = "15",
doi = "10.1002/ijc.21720",
language = "English (US)",
volume = "118",
pages = "3062--3071",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Real-time detection of epidermal growth factor receptor expression in fresh oral cavity biopsies using a molecular-specific contrast agent

AU - Hsu, Elizabeth R.

AU - Gillenwater, Ann M.

AU - Hasan, M. Qasim

AU - Williams, Michelle D.

AU - El-Naggar, Adel K.

AU - Richards-Kortum, Rebecca R.

PY - 2006/6/15

Y1 - 2006/6/15

N2 - Early diagnosis of individuals with high risk of developing head and neck squamous carcinoma should lead to decreased morbidity and increased survival. To aid in noninvasive early detection of oral neoplasia in vivo, we have developed a molecular-specific fluorescent contrast agent, consisting of a far-red fluorescent dye coupled to a monoclonal antibody targeted against the epidermal growth factor receptor. In our study, we used organ cultures of normal and neoplastic human oral tissue to evaluate the capabilities of using this contrast agent to enhance clinical diagnosis. Fresh tissue sections were prepared from 34 biopsies of clinically normal and abnormal oral mucosa from 17 consenting patients. Samples were exposed to contrast agent, rinsed and the presence of bound agent was detected using fluorescence confocal microscopy. Simple assays to assess cytotoxicity of the dye used in the agent and to determine labeling efficacy at physiologic temperatures were also performed. Results indicate that the mean fluorescence intensity (MFI) of samples with dysplasia and cancer are higher than that of the normal sample from the same patient, and that this increase in fluorescence could potentially be used in the early detection and delineation of premalignant lesions. Normal tissue could be distinguished from cancer or moderate dysplasia, using either the ratio of the MFI of abnormal to normal tissue or the MFI obtained from the epithelial surface. No detrimental effects from the dye were observed over a 4-day period. These results indicate that the use of this optical contrast agent could yield important clinical advantages for noninvasive early detection and molecular characterization of oral mucosa.

AB - Early diagnosis of individuals with high risk of developing head and neck squamous carcinoma should lead to decreased morbidity and increased survival. To aid in noninvasive early detection of oral neoplasia in vivo, we have developed a molecular-specific fluorescent contrast agent, consisting of a far-red fluorescent dye coupled to a monoclonal antibody targeted against the epidermal growth factor receptor. In our study, we used organ cultures of normal and neoplastic human oral tissue to evaluate the capabilities of using this contrast agent to enhance clinical diagnosis. Fresh tissue sections were prepared from 34 biopsies of clinically normal and abnormal oral mucosa from 17 consenting patients. Samples were exposed to contrast agent, rinsed and the presence of bound agent was detected using fluorescence confocal microscopy. Simple assays to assess cytotoxicity of the dye used in the agent and to determine labeling efficacy at physiologic temperatures were also performed. Results indicate that the mean fluorescence intensity (MFI) of samples with dysplasia and cancer are higher than that of the normal sample from the same patient, and that this increase in fluorescence could potentially be used in the early detection and delineation of premalignant lesions. Normal tissue could be distinguished from cancer or moderate dysplasia, using either the ratio of the MFI of abnormal to normal tissue or the MFI obtained from the epithelial surface. No detrimental effects from the dye were observed over a 4-day period. These results indicate that the use of this optical contrast agent could yield important clinical advantages for noninvasive early detection and molecular characterization of oral mucosa.

KW - Epidermal growth factor receptor

KW - Fluorescent contrast agent

KW - Molecular-specific contrast agent

UR - http://www.scopus.com/inward/record.url?scp=33646417361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646417361&partnerID=8YFLogxK

U2 - 10.1002/ijc.21720

DO - 10.1002/ijc.21720

M3 - Article

C2 - 16395711

AN - SCOPUS:33646417361

VL - 118

SP - 3062

EP - 3071

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 12

ER -